A Phase I/II Study Using Cisplatin and Gemcitabine (Gemzar) for Advanced Head and Neck Cancer (Squamous Cell Carcinoma).
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Mar 2010 Planned number of patients changed from 3 to 40.
- 23 Sep 2005 New trial record.